Anchiano Therapeutics Ltd.
|Number of Estimates|
Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel.
Market Cap: 16.9 Million
Primary Exchange: NASDAQ
Shares Outstanding: 7.36 Million
Sector: Health Technology
Short Interest ():
Longest drawdown: 193 trading days
From: 2019-02-15 To: 2019-11-12
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|